SPY314.38-1.80 -0.57%
DIA257.24-3.48 -1.33%
IXIC10,547.75+55.25 0.53%

Stifel Maintains Buy on IGM Biosciences, Raises Price Target to $95

Stifel maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $67 to $95.

Benzinga · -
Stifel maintains IGM Biosciences (NASDAQ: IGMS) with a Buy and raises the price target from $67 to $95.